TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 44 filers reported holding TALIS BIOMEDICAL CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $43,902 | +54777.5% | 91,463 | -44.1% | 0.00% | – |
| Q1 2023 | $80 | +63.3% | 163,663 | +47.4% | 0.00% | – |
| Q4 2022 | $49 | -99.9% | 111,036 | -14.2% | 0.00% | – |
| Q3 2022 | $88,000 | -46.3% | 129,372 | -35.9% | 0.00% | – |
| Q2 2022 | $164,000 | +4.5% | 201,913 | +1320.0% | 0.00% | – |
| Q2 2021 | $157,000 | – | 14,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|